12 news items
Adial Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
ADIL
15 May 24
and Trademark Office in 2024. First, we were awarded patent number 11,905,562, which further protects AD04 and covers its unique ability to target
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
ADIL
AEYE
ATHE
15 Apr 24
analyst Dave Kang upgraded Extreme Networks from Neutral to Buy and maintained a $14 price target.
Losers
Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session
ADIL
AGEN
AGX
12 Apr 24
maintained Lovesac with a Buy and lowered the price target from $34 to $30.
Applied Digital Corporation
Why Ascent Solar Technologies Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
ACB
ACORQ
ADIL
10 Apr 24
. (NASDAQ:DCGO) fell 18.2% to $3.15. Stifel analyst David Grossman maintained DocGo with a Buy and lowered the price target from $11
Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder
ADIL
10 Apr 24
on the development of treatments for addictions and related disorders. The Company's lead investigational new drug product, AD04, is a genetically targeted
mae3m7e6xwoodcbgn28dl17j h7gbkhlt
ADIL
10 Apr 24
Pharmaceuticals received a U.S. patent covering AD04 and its ability to target the serotonin transporter gene for the potential treatment
t14rh0aaqp9wa2blwgxsc8i5v987lrt3xgg8ltwypobxfice4v5xw 2j2l23
ADIL
1 Mar 24
investigational new drug product, AD04, is a genetically targeted, serotonin-3 receptor antagonist, therapeutic agent for the treatment of Alcohol
c683re56125ucotx4fybegb2mthl7wl8d p1mqqsdvtmugkrr7y6f1lf
ACIC
ADIL
ARVN
1 Mar 24
. Jefferies analyst Yaron Kinar upgraded Root from Hold to Buy and raised the price target from $10 to $40.
MasTec, Inc
kgqzquuxk u98uy6wec8qrrzuc6nzifctrugq
ADIL
AGFY
AI
29 Feb 24
, UBS maintained a Neutral rating on the stock and raised its price target from $38 to $44.
Duolingo, Inc
ab2f7y2n9t16mogch30yka19u9vh4zvr95b61 cdv
ADIL
28 Feb 24
Office on Feb. 20 and covers the company's lead investigational new drug product, AD04, and its ability to target the serotonin transporter gene
q6ud1tvk13qb14v1vayjvxm71y48osa3sicdxvex1hkg1j9qzbiqrrf1id
ADIL
28 Feb 24
and Trademark Office. The patent covers the Company's lead investigational new drug product, AD04, and its ability to target the serotonin transporter gene
g0qecva1
ADIL
28 Feb 24
covers the company’s lead investigational new drug product, AD04, and its ability to target the serotonin transporter gene for the potential
- Prev
- 1
- Next